• Popular anticonvulsant (with a multitude of off-label pain uses) gains approval to go generic.
• A Web-based provider of care analytics has come up with a prostate cancer screen. The cynic in me says it’s a new look to an old unresolved problem.

Through a web-based tool, men enter the results of their PSA test history and personal information such as height, weight and health history. This information is compared with up to a million case studies and outcomes from other men with various prostate conditions. Finally, the system may suggest a medical detective process for doctors and their patients in their efforts to detect non-cancerous prostate conditions and improve prostate cancer screening, the company said.

• Lilly is trying very hard to get a novel neuroleptic to market; it’s not going too well.
• Crestor, an popular cholesterol drug, to protect against venous blood clots? | VIDEO
• CA spice company linked to Salmonella outbreak. | LINK

Related Posts Within Doctor Pundit:

1. Monday Newswire: MN’s First Influenza-A Case & More NY state recoups over half a billion dollars in amounts...
2. Patient Advocacy Group on Prostate Cancer Gets Serious about Prevention – Zero prostate cancer deaths. Zero prostate cancer cases and for...
3. Report: Pharma Company Covered Up Known Cardiovascular Risks of Drug GSK (then known as SmithKline Beecham) knew in a 1999...
4. US Settles Suit against Pharma Manufacturer over Vitamin Claims Kinda reminds me of the ol’ snake oil days. Bayer...
5. Report: Branded Drug Use Sharply Down, Generics Way Up A healthcare informatics company issues a report today that I...